Search Results 311-320 of 27227 for Two-phase
To specifically address the relative increase in CNS events this study will test safety and efficacy of these two therapeutic interventions. ... Phase 2 (stage 2): ...
The primary objective of Substudy 2 (Phase 3 induction) is to evaluate the ... This two-part, part 1: open-label extension (OLE) and part 2: safety ...
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
Phase 1-2 dose escalation randomized study in patients with intermediate or high risk myelodysplastic syndromes (MDS) or acute myelogenous leukemia (AML).
This is a single arm, open-label, multi-center, phase 1/2 study, to determine the safety and efficacy of KTE-C19, an autologous anti-CD19 chimeric antigen ...
About this study. PSSc-001 (LOTUSS) This study is a Phase 2, multinational, open-label, randomized, parallel-group, safety and tolerability study of ...
Researchers wondered if it is diabetes of the brain, could insulin delivered in an intranasal mist help patients? The results of a phase 2 clinical trial have ...
The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.